Evidence
Alzheimers Dement. 2024 Sep 24. doi: 10.1002/alz.14247. Online ahead of print.
ABSTRACT
INTRODUCTION: We investigated the prevalence of amyloid beta (Aβ) positivity (+) and cognitive trajectories in Koreans and non-Hispanic Whites (NHWs).
METHODS: We included 5121 Koreans from multiple centers across South Korea and 929 NHWs from the Alzheimer’s Disease Neuroimaging Initiative (ADNI). Participants underwent Aβ positron emission tomography and were categorized into cognitively unimpaired (CU), mild cognitive impairment (MCI), and dementia stages. Age, sex, education, and apolipoprotein E. genotype were adjusted using multivariable logistic regression and stabilized inverse probability of treatment weights based on the propensity scores to mitigate imbalances in these variables.
RESULTS: The prevalence of Aβ+ was lower in CU Koreans than in CU NHWs (adjusted odds ratio 0.60). Aβ+ Koreans showed a faster cognitive decline than Aβ+ NHWs in the CU (B = -0.314, p = .004) and MCI stages (B = -0.385, p < .001).
DISCUSSION: Ethnic characteristics of Aβ biomarkers should be considered in research and clinical application of Aβ-targeted therapies in diverse populations.
HIGHLIGHTS: Koreans have a lower prevalence of Aβ positivity compared to NHWs in the CU stage. The effects of Alzheimer’s risk factors on Aβ positivity differ between Koreans and NHWs. Aβ-positive (Aβ+) Koreans show faster cognitive decline than Aβ+ NHWs in the CU and MCI stages.
PMID:39315862 | DOI:10.1002/alz.14247
Estimated reading time: 4 minute(s)
Latest: Psychiatryai.com #RAISR4D Evidence
Cool Evidence: Engaging Young People and Students in Real-World Evidence ☀️
Real-Time Evidence Search [Psychiatry]
AI Research
Ethnic differences in the prevalence of amyloid positivity and cognitive trajectories
🌐 90 Days
AI Virtual Reality Related Evidence Matrix
- Assessing amyloid PET positivity and cognitive function in Down syndrome to guide clinical trials targeting amyloid
- Self- and study partner-reported cognitive decline in older adults without dementia: The role of alpha-synuclein and amyloid biomarkers in the Alzheimer's Disease Neuroimaging Initiative
- The Alzheimer's Disease Neuroimaging Initiative Clinical Core
- Assessing cognitive impairment and disability in older adults through the lens of whole brain white matter patterns
- Assessing cognitive impairment and disability in older adults through the lens of whole brain white matter patterns
- Temporo-frontoparietal hypoconnectivity as a biomarker for isolated language impairment in mild cognitive impairment: A cross-cohort comparison
- Contributions of the ADNI Biostatistics Core
- Amyloid and SCD jointly predict cognitive decline across Chinese and German cohorts
- Validation of regression-based change formulae for mild cognitive impairment and Alzheimer's disease
- Predicting Cognitive Decline in Amyloid-Positive Patients With Mild Cognitive Impairment or Mild Dementia
- Comparison of deep learning architectures for predicting amyloid positivity in Alzheimer's disease, mild cognitive impairment, and healthy aging, from T1-weighted brain structural MRI
- Amyloid PET disclosure in subjective cognitive decline: Patient experiences over time
- Amyloid PET disclosure in subjective cognitive decline: Patient experiences over time
- Identifying longitudinal cognitive resilience from cross-sectional amyloid, tau, and neurodegeneration
- A prediction model of dementia conversion for mild cognitive impairment by combining plasma pTau181 and structural imaging features
- Psychosis in Alzheimer Disease and Elevations in Disease-Relevant Biomarkers
- Storyteller in ADNI4: Application of an early Alzheimer's disease screening tool using brief, remote, and speech-based testing
- Tau pathology mediate the plasma biomarkers and cognitive function in patients with mild cognitive impairment
- Impact of amyloid and cardiometabolic risk factors on prognostic capacity of plasma neurofilament light chain for neurodegeneration
- Unexpected Low Rate of Amyloid-β Pathology in Multiple Sclerosis Patients
- Risk factors for cognitive decline in non-demented elders with amyloid-beta positivity
- Real-world performance of plasma p-tau181 in a heterogeneous memory clinic cohort
- CSF glial biomarkers are associated with cognition in individuals at risk of Alzheimer's disease
- Florbetaben amyloid PET acquisition time: Influence on Centiloids and interpretation
- EEG Functional Connectivity Differences Predict Future Conversion to Dementia in Mild Cognitive Impairment With Lewy Body or Alzheimer Disease
- EEG Functional Connectivity Differences Predict Future Conversion to Dementia in Mild Cognitive Impairment With Lewy Body or Alzheimer Disease
- Association of Seizure Control With Cognition in People With Normal Cognition and Mild Cognitive Impairment
- Effects of strategic white matter hyperintensities of cholinergic pathways on basal forebrain volume in patients with amyloid-negative neurocognitive disorders
- Characterizing the clinical heterogeneity of early symptomatic Alzheimer's disease: a data-driven machine learning approach
- Characterizing the clinical heterogeneity of early symptomatic Alzheimer's disease: a data-driven machine learning approach
- Hormone therapy is associated with lower Alzheimer's disease tau biomarkers in post-menopausal females -evidence from two independent cohorts
- Hormone therapy is associated with lower Alzheimer's disease tau biomarkers in post-menopausal females -evidence from two independent cohorts
- Revised criteria for diagnosis and staging of Alzheimer's disease: Alzheimer's Association Workgroup
- Reasons for undergoing amyloid imaging among diverse enrollees in the A4 study
- Neuroimaging correlates of Alzheimer's disease biomarker concentrations in a racially diverse high-risk cohort of middle-aged adults
- Profiling aducanumab as a treatment option for alzheimer's disease: an overview of efficacy, safety and tolerability
- Development of thresholds and a visualization tool for use of a blood test in routine clinical dementia practice
- CYP1B1-RMDN2 Alzheimer's disease endophenotype locus identified for cerebral tau PET
- Psychological well-being trajectories preceding incident mild cognitive impairment and dementia
- Subjective Cognitive Decline Plus and Longitudinal Assessment and Risk for Cognitive Impairment
- Cerebrospinal fluid p-tau181, 217, and 231 in definite Creutzfeldt-Jakob disease with and without concomitant pathologies
- Association of neuroticism with incident dementia, neuroimaging outcomes, and cognitive function
- Differences in the cerebral amyloid angiopathy proteome in Alzheimer's disease and mild cognitive impairment
- The relationship between adult hippocampal neurogenesis and cognitive impairment in Alzheimer's disease
- Traumatic Brain Injury, Seizures, and Cognitive Impairment Among Older Adults
- Association of Neurogranin and BACE1 With Clinical Cognitive Decline in Individuals With Subjective Cognitive Decline
- Digital remote assessment of speech acoustics in cognitively unimpaired adults: feasibility, reliability and associations with amyloid pathology
- Assessing blood-brain barrier dysfunction and its association with Alzheimer's pathology, cognitive impairment and neuroinflammation
- Association of Neurogranin and BACE1 With Clinical Cognitive Decline in Individuals With Subjective Cognitive Decline
- A Framework for Best Practices and Readiness in the Advent of Anti-Amyloid Therapy for Early Alzheimer's Disease in Asia
- Lewy body pathology exacerbates brain hypometabolism and cognitive decline in Alzheimer's disease
- Loneliness, cerebrovascular and Alzheimer's disease pathology, and cognition
- Associations of Amyloid Burden, White Matter Hyperintensities, and Hippocampal Volume With Cognitive Trajectories in the 90+ Study
- Associations of Amyloid Burden, White Matter Hyperintensities, and Hippocampal Volume With Cognitive Trajectories in the 90+ Study
- Cerebral glucose metabolism in Alzheimer's disease
- Alzheimer's Association launches new journal on the impacts of behavioral, social, and economic factors on health and dementia care in aging
- Personality and Transition From Mild Cognitive Impairment to Normal Cognition vs Dementia
- Association Between Tongue Pressure and Prevalence of Mild Cognitive Impairment in Japan
- Associations of cerebrovascular disease and Alzheimer's disease pathology with cognitive decline: Analysis of the National Alzheimer's Coordinating Center Uniform Data Set
- Influence of Different Diagnostic Criteria on Alzheimer Disease Clinical Research
- Clonal hematopoiesis of indeterminate potential is associated with reduced risk of cognitive impairment in patients with chronic kidney disease
- Association of Heart Failure With Cognitive Decline and Development of Mild Cognitive Impairment and Dementia
- Derivation of Indices of Cognitive Change Among Hispanic Adults and Elders
- Sex-specific clinical and neurobiological correlates of fatigue in older adults
Evidence Blueprint
Ethnic differences in the prevalence of amyloid positivity and cognitive trajectories
☊ AI-Driven Related Evidence Nodes
(recent articles with at least 5 words in title)
More Evidence
Ethnic differences in the prevalence of amyloid positivity and cognitive trajectories
🌐 365 Days
AI Virtual Reality Related Evidence Matrix
- Assessing amyloid PET positivity and cognitive function in Down syndrome to guide clinical trials targeting amyloid
- A cross-sectional study of α-synuclein seed amplification assay in Alzheimer's disease neuroimaging initiative: Prevalence and associations with Alzheimer's disease biomarkers and cognitive function
- Self- and study partner-reported cognitive decline in older adults without dementia: The role of alpha-synuclein and amyloid biomarkers in the Alzheimer's Disease Neuroimaging Initiative
- Glymphatic system dysfunction predicts amyloid deposition, neurodegeneration, and clinical progression in Alzheimer's disease
- The Alzheimer's Disease Neuroimaging Initiative Clinical Core
- Assessing cognitive impairment and disability in older adults through the lens of whole brain white matter patterns
- Assessing cognitive impairment and disability in older adults through the lens of whole brain white matter patterns
- Diabetes accelerates Alzheimer's disease progression in the first year post mild cognitive impairment diagnosis
- Associations among plasma, MRI, and amyloid PET biomarkers of Alzheimer's disease and related dementias and the impact of health-related comorbidities in a community-dwelling cohort
- Multimorbidity, cognitive phenotypes, and Alzheimer's disease plasma biomarkers in older adults: A population-based study
- Effects of the active amyloid beta immunotherapy CAD106 on PET measurements of amyloid plaque deposition in cognitively unimpaired APOE ε4 homozygotes
- Temporo-frontoparietal hypoconnectivity as a biomarker for isolated language impairment in mild cognitive impairment: A cross-cohort comparison
- Contributions of the ADNI Biostatistics Core
- Amyloid and SCD jointly predict cognitive decline across Chinese and German cohorts
- Validation of regression-based change formulae for mild cognitive impairment and Alzheimer's disease
- Machine learning prediction of future amyloid beta positivity in amyloid-negative individuals
- Machine learning prediction of future amyloid beta positivity in amyloid-negative individuals
- Pathophysiology characterization of Alzheimer's disease in South China's aging population: for the Greater-Bay-Area Healthy Aging Brain Study (GHABS)
- Predicting Cognitive Decline in Amyloid-Positive Patients With Mild Cognitive Impairment or Mild Dementia
- Epidemiology and prevalence of dementia and Alzheimer's disease in American Indians: Data from the Strong Heart Study
- Comparison of deep learning architectures for predicting amyloid positivity in Alzheimer's disease, mild cognitive impairment, and healthy aging, from T1-weighted brain structural MRI
- Investigating alpha-synuclein co-pathology in Alzheimer's disease by means of cerebrospinal fluid alpha-synuclein seed amplification assay
- Examining amyloid reduction as a surrogate endpoint through latent class analysis using clinical trial data for dominantly inherited Alzheimer's disease
- Subsequent correlated changes in complement component 3 and amyloid beta oligomers in the blood of patients with Alzheimer's disease
- Inferior Frontal Sulcal Hyperintensities on Brain MRI Are Associated with Amyloid Positivity beyond Age-Results from the Multicentre Observational DELCODE Study
- Impact of amyloid and tau positivity on longitudinal brain atrophy in cognitively normal individuals
- Amyloid PET disclosure in subjective cognitive decline: Patient experiences over time
- Amyloid PET disclosure in subjective cognitive decline: Patient experiences over time
- Identifying longitudinal cognitive resilience from cross-sectional amyloid, tau, and neurodegeneration
- A prediction model of dementia conversion for mild cognitive impairment by combining plasma pTau181 and structural imaging features
- Post-disclosure distress among racial and ethnic groups in a preclinical AD trial
- Trajectories of Occupational Cognitive Demands and Risk of Mild Cognitive Impairment and Dementia in Later Life: The HUNT4 70+ Study
- Predicting functional decline in aging and Alzheimer's disease with PET-based Braak staging
- Comparison of plasma and neuroimaging biomarkers to predict cognitive decline in non-demented memory clinic patients
- Combining plasma Aβ and p-tau217 improves detection of brain amyloid in non-demented elderly
- Characteristics of discordance between amyloid positron emission tomography and plasma amyloid-β 42/40 positivity
- Psychosis in Alzheimer Disease and Elevations in Disease-Relevant Biomarkers
- Predictors and outcomes of fluctuations in the clinical dementia rating scale
- Head-to-Head Comparison of Tau and Amyloid Positron Emission Tomography Visual Reads for Differential Diagnosis of Neurodegenerative Disorders: An International, Multicenter Study
- Suboptimal self-reported sleep efficiency and duration are associated with faster accumulation of brain amyloid beta in cognitively unimpaired older adults
- High Contrast PET Imaging of Subcortical and Allocortical Amyloid-β in Early Alzheimer's Disease Using [11C]AZD2184
- Storyteller in ADNI4: Application of an early Alzheimer's disease screening tool using brief, remote, and speech-based testing
- Association between clinical dementia rating and clinical outcomes in Alzheimer's disease
- Tau pathology mediate the plasma biomarkers and cognitive function in patients with mild cognitive impairment
- APOE ε4 carrier status modifies plasma p-tau181 concentrations in cognitively healthy super-seniors
- Elevated Amyloid-β PET Scan and Cognitive and Functional Decline in Mild Cognitive Impairment and Dementia of Uncertain Etiology
- Prevalence of mild behavioural impairment and its association with cognitive and functional impairment in normal cognition, mild cognitive impairment, and mild Alzheimer's dementia
- Contribution of Global Amyloid-PET Imaging for Predicting Future Cognition in the MEMENTO Cohort
- Impact of amyloid and cardiometabolic risk factors on prognostic capacity of plasma neurofilament light chain for neurodegeneration
- Development of disease-modifying therapies against Alzheimer's disease
- Performance of a [18F]Flortaucipir PET Visual Read Method Across the Alzheimer Disease Continuum and in Dementia With Lewy Bodies
- Unexpected Low Rate of Amyloid-β Pathology in Multiple Sclerosis Patients
- Cortical gray to white matter signal intensity ratio as a sign of neurodegeneration and cognition independent of β-amyloid in dementia
- Polygenic effects on the risk of Alzheimer's disease in the Japanese population
- Tau accumulation and its spatial progression across the Alzheimer's disease spectrum
- Racial differences in the effect of APOE-ε4 genotypes on trail making test B in Alzheimer's disease: A longitudinal study
- Risk factors for cognitive decline in non-demented elders with amyloid-beta positivity
- Specific Association of Worry With Amyloid-β But Not Tau in Cognitively Unimpaired Older Adults
- Association of beta-Amyloid, Microglial Activation, Cortical Thickness, and Metabolism in Older Adults Without Dementia
- Tau Positron Emission Tomography for Predicting Dementia in Individuals With Mild Cognitive Impairment
- Retina pathology as a target for biomarkers for Alzheimer's disease: Current status, ophthalmopathological background, challenges, and future directions
- Real-world performance of plasma p-tau181 in a heterogeneous memory clinic cohort
- Clinical variables contributing to the identification of biologically defined subgroups within cognitively unimpaired and mild cognitive impairment individuals
- Effect of apolipoprotein E ε4 and its modification by sociodemographic characteristics on cognitive measures in South Asians from LASI-DAD